Cargando…

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis

BACKGROUND: Epidemiological literature regarding the effect of polycystic ovary syndrome (PCOS) as a risk factor for non-alcoholic fatty liver disease (NAFLD) remains inconsistent. Furthermore, it remains debatable whether NAFLD is associated with PCOS as a consequence of shared risk factors or whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jia, Yao, Xin-Yu, Shi, Ru-Xia, Liu, Su-Fen, Wang, Xiao-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946415/ https://www.ncbi.nlm.nih.gov/pubmed/29747678 http://dx.doi.org/10.1186/s12978-018-0519-2

Ejemplares similares

Non-alcoholic fatty liver disease in polycystic ovary syndrome women
por: Won, Young Bin, et al.
Publicado: (2021)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Manzano-Nunez, Ramiro, et al.
Publicado: (2023)

Non‐alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta‐analysis
por: Shengir, Mohamed, et al.
Publicado: (2021)

Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease
por: Zhang, Jianhai, et al.
Publicado: (2018)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
por: Shahbaz, Mahrukh, et al.
Publicado: (2022)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

Update on Animal Models of Polycystic Ovary Syndrome
por: Stener-Victorin, Elisabet
Publicado: (2022)

Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography
por: Lavor, Claruza Braga Holanda, et al.
Publicado: (2022)

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis
por: Kaur, Mandeep, et al.
Publicado: (2023)

Potential for NPY receptor–related therapies for polycystic ovary syndrome: an updated review
por: Chen, Wei-hong, et al.
Publicado: (2023)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race Against the Clock
por: Huffman, Alexandra M, et al.
Publicado: (2022)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome
por: Liu, Dong, et al.
Publicado: (2023)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Updating the polycystic ovary syndrome diagnosis: Does ultrasound matter?
por: Komorowski, Allison S., et al.
Publicado: (2023)

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
por: Asfari, Mohammad Maysara, et al.
Publicado: (2020)

Sex Hormone-Binding Globulin (SHBG) Reduction: The Alarm Bell for the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome
por: Urbano, Flavia, et al.
Publicado: (2022)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
por: Tan, Susanne, et al.
Publicado: (2015)

Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan
por: Kubota, Toshiro
Publicado: (2013)

Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome
por: Kostroun, Katherine E., et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: an update on diagnosis
por: DUMITRASCU, DAN L., et al.
Publicado: (2018)

Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis
por: Yang, Kailin, et al.
Publicado: (2018)

Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)
por: Zumbro, Emily L., et al.
Publicado: (2021)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
por: Spremović Rađenović, Svetlana, et al.
Publicado: (2022)

Tanshinone for polycystic ovary syndrome: A protocol of systematic review and meta-analysis
por: Yang, Yijiao, et al.
Publicado: (2021)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70r5spu7q89vipk2177jen5mna